Receptor, ErbB-2, antagonists & inhibitors

Receptor, ErbB-2, antagonists & inhibitors
Accession Number

Not Available

DrugDrug Description
AV-412Investigated for use/treatment in cancer/tumors (unspecified).
PertuzumabAn antineoplastic agent used in the treatment of HER2-positive metastatic breast cancer in combination with other antineoplastic agents.
TesevatinibTesevatinib has been used in trials studying the treatment of Cancer, Stomach Cancer, Brain Metastases, Esophageal Cancer, and Leptomeningeal Metastases, among others. Tesevatinib is a potent inhibitor of multiple RTKs...
CP-724714CP-724,714 has been used in trials studying the treatment of Breast Cancer, Breast Neoplasms, and Neoplasm Metastasis.
Drugs & Drug Targets
AV-412Epidermal growth factor receptortarget
AV-412Receptor tyrosine-protein kinase erbB-2target
PertuzumabReceptor tyrosine-protein kinase erbB-2target
TesevatinibPro-epidermal growth factortarget
TesevatinibEphrin type-B receptor 4target
TesevatinibReceptor tyrosine-protein kinase erbB-2target